ArticleLeukemia2011

The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival.

A Scuto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.